Article
High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening
14 Nov 2020
Abstract excerpt
PURPOSE: The percentage of a maternal cell-free DNA (cfDNA) sample that is fetal-derived (the fetal fraction; FF) is a key driver of the sensitivity and specificity of noninvasive prenatal screening (NIPS). On certain NIPS platforms, >20% of women with high body mass index (and >5% overall) receive a test failure due to low FF (<4%). METHODS: A scalable fetal fraction amplification (FFA) technology was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
